---
title: "Eton Pharmaceuticals 在获得 FDA 批准后股价上涨，但随后涨幅收窄"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276935023.md"
description: "Eton Pharmaceuticals 的股票在 FDA 批准 Desmoda 用于治疗中央性尿崩症后最初上涨，但随后下跌了 1.5%，至 18 美元。该股票在公告后最高达到 19.98 美元。Eton 计划于 3 月 9 日推出 Desmoda，预计年峰值销售额为 3000 万至 5000 万美元"
datetime: "2026-02-25T20:41:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276935023.md)
  - [en](https://longbridge.com/en/news/276935023.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276935023.md)
---

# Eton Pharmaceuticals 在获得 FDA 批准后股价上涨，但随后涨幅收窄

By Josh Beckerman

Shares of Eton Pharmaceuticals initially rose but pared their gains after the Food and Drug Administration approved Desmoda oral solution for management of central diabetes insipidus as antidiuretic replacement therapy.

Prior to a trading halt before the company's announcement, shares were at $17.69. The stock peaked at $19.98 Wednesday afternoon but was recently down 1.5% for the day at $18.

Eton expects a March 9 commercial launch for Desmoda, an oral liquid formulation of desmopressin. The company expects product peak sales of $30 million to $50 million annually.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

February 25, 2026 15:29 ET (20:29 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

### 相关股票

- [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [ETON.US](https://longbridge.com/zh-CN/quote/ETON.US.md)
- [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md)
- [IXJ.US](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md)

## 相关资讯与研究

- [减肥药公司 Kailera TherapeuticsIPO 定价 14-16 美元/股 拟周五登陆纳斯达克](https://longbridge.com/zh-CN/news/282645838.md)
- [诺和诺德携手 OpenAI 加速药物研发 旨在提升效率](https://longbridge.com/zh-CN/news/282699021.md)
- [新一代 COPD 大药来了？](https://longbridge.com/zh-CN/news/282618672.md)
- [癌症之王迎来靶向药突破](https://longbridge.com/zh-CN/news/282757024.md)
- [Revolution Medicines 胰腺癌药物取得成功](https://longbridge.com/zh-CN/news/282698153.md)